Hee Cheol Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hee Cheol Kim has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Jin Cheon Kim
Department of Colon and Rectal Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
15 shared publicationsChang Sik Yu
Colorectal Clinic, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
11 shared publications- In Ja Park
Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
6 shared publications - Chang Sik Yu
Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
4 shared publications Dae Dong Kim
Colorectal Clinic, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
3 shared publicationsSang Hun Jung
Colorectal Clinic, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2008
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 23 (2) , 270-277
CpG Island Methylation in Familial Colorectal Cancer Patients Not Fulfilling the Amsterdam Criteria
Kim HC, et al. J Korean Med Sci. 2008 Apr;23(2):270-277. http://dx.doi.org/10.3346/jkms.2008.23.2.270
- 1 January 2008
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 23 (2) , 270-277
Open AccessCpG Island Methylation in Familial Colorectal Cancer Patients Not Fulfilling the Amsterdam Criteria
Kim HC, et al. J Korean Med Sci. 2008 Apr;23(2):270-277. http://dx.doi.org/10.3346/jkms.2008.23.2.270
- Open Access
- 1 January 2008
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 24 (2) , 100-106
Outcomes after a Hepatic Resection for Multiple Hepatic Metastases from Colorectal Cancer
Choi PW, et al. J Korean Soc Coloproctol. 2008 Apr;24(2):100-106. http://dx.doi.org/10.3393/jksc.2008.24.2.100
- 1 January 2008
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 24 (2) , 100-106
Open AccessOutcomes after a Hepatic Resection for Multiple Hepatic Metastases from Colorectal Cancer
Choi PW, et al. J Korean Soc Coloproctol. 2008 Apr;24(2):100-106. http://dx.doi.org/10.3393/jksc.2008.24.2.100
- 20 September 2007
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (1) , 227-232
Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery
We compared outcomes of surgery and radiofrequency thermal ablation (RFA) in patients with metachronous liver metastases. Between October 1995 and December 2005, 59 patients underwent hepatic resection and 30 underwent RFA for metachronous liver metastases. Patients with extra-hepatic metastases, those who underwent both types of treatment, and those with synchronous hepatic metastasis were excluded. The two groups had similar mean age, sex ratio, comorbid medical conditions, primary disease stage, and frequency of solitary metastases. Preoperative mean serum carcinoembryonic antigen (CEA) level was significantly higher in the RFA group (13.4 ng/mL vs. 7.7 ng/mL; p = 0.02). Mean diameter of hepatic metastases was significantly greater in the resection than in the RFA group (3.1 cm vs. 2.0 cm; p = 0.001). Recurrence after treatment of metastasis was observed in 18 of 30 (60.0%) RFA and 33 of 59 (56%) resection patients. Local recurrence at the RFA site was observed in 7 of 30 (23%) patients. Time to recurrence (15 vs. 8 months, p = 0.02) and overall survival (56 vs. 36 months, p = 0.005) were significantly longer in the resection than in the RFA group. In the 69 patients with solitary metastases of diameter ≤3 cm, time to recurrence (p = 0.004) and overall survival were significantly greater in the resection group. Compared with hepatic resection, RFA for metachronous hepatic metastases from colorectal cancer was associated with higher local recurrence and shorter recurrence-free and overall survival rates, even in patients with solitary, small (≤3 cm) lesions.
- 20 September 2007
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (1) , 227-232
Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery
We compared outcomes of surgery and radiofrequency thermal ablation (RFA) in patients with metachronous liver metastases. Between October 1995 and December 2005, 59 patients underwent hepatic resection and 30 underwent RFA for metachronous liver metastases. Patients with extra-hepatic metastases, those who underwent both types of treatment, and those with synchronous hepatic metastasis were excluded. The two groups had similar mean age, sex ratio, comorbid medical conditions, primary disease stage, and frequency of solitary metastases. Preoperative mean serum carcinoembryonic antigen (CEA) level was significantly higher in the RFA group (13.4 ng/mL vs. 7.7 ng/mL; p = 0.02). Mean diameter of hepatic metastases was significantly greater in the resection than in the RFA group (3.1 cm vs. 2.0 cm; p = 0.001). Recurrence after treatment of metastasis was observed in 18 of 30 (60.0%) RFA and 33 of 59 (56%) resection patients. Local recurrence at the RFA site was observed in 7 of 30 (23%) patients. Time to recurrence (15 vs. 8 months, p = 0.02) and overall survival (56 vs. 36 months, p = 0.005) were significantly longer in the resection than in the RFA group. In the 69 patients with solitary metastases of diameter ≤3 cm, time to recurrence (p = 0.004) and overall survival were significantly greater in the resection group. Compared with hepatic resection, RFA for metachronous hepatic metastases from colorectal cancer was associated with higher local recurrence and shorter recurrence-free and overall survival rates, even in patients with solitary, small (≤3 cm) lesions.
- 1 August 2007
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 189 (2) , 283-289
CT Colonography for Follow-Up After Surgery for Colorectal Cancer
OBJECTIVE. The purpose of this article is to discuss the CT colonography (CTC) findings and the role of CTC for follow-up after curative surgery for colorectal cancer. CONCLUSION. Contrast-enhanced CTC can be effective for surveillance for colorectal cancer recurrence after curative surgery because it enables simultaneous evaluation of distant abdominal metastasis, pericolic recurrence, intraluminal recurrence, and metachronous lesions. The appearances of anastomotic recurrences at CTC overlap with those of more common inflammatory polyps and rare benign ulcers.
- 1 August 2007
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 189 (2) , 283-289
CT Colonography for Follow-Up After Surgery for Colorectal Cancer
OBJECTIVE. The purpose of this article is to discuss the CT colonography (CTC) findings and the role of CTC for follow-up after curative surgery for colorectal cancer. CONCLUSION. Contrast-enhanced CTC can be effective for surveillance for colorectal cancer recurrence after curative surgery because it enables simultaneous evaluation of distant abdominal metastasis, pericolic recurrence, intraluminal recurrence, and metachronous lesions. The appearances of anastomotic recurrences at CTC overlap with those of more common inflammatory polyps and rare benign ulcers.
- Open Access
- 30 June 2007
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 1 (1) , 082-086
Solitary Preleukemic Granulocytic Sarcoma as a Cause of Small Bowel Obstruction
Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytic cells. These tumors usually occur simultaneously with or follow after the onset of acute myeloid leukemia (AML) or other myeloproliferative disorders. Rarely, it is the first manifestation of AML which appears several months before the onset of leukemia. We report a case of a 48-year-old man presenting with symptoms of small bowel obstruction. Laparotomy and open biopsy were performed. Immunohistochemical studies showed that the neoplastic cells were of myeloid lineage positive for myeloperoxidase and leukocyte common antigen, but negative for CD3, 20, 56, 79a, and cytokeratin. Initially, there was no evidence of blood or bone marrow involvement suggesting acute leukemia or other myeloproliferative disorders. The findings were consistent with the diagnostic findings of solitary granulocytic sarcoma (preleukemic). However, one month later, bone marrow biopsy revealed 57% myeloblasts. Sequentially, the patient developed FAB M2 acute myeloid leukemia. Induction chemotherapy including cytarabine and idarubicine was done which led to complete remission. Allograft bone marrow transplantation was performed later, and there is no evidence of recurrence till present.
- 30 June 2007
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 1 (1) , 082-086
Open AccessSolitary Preleukemic Granulocytic Sarcoma as a Cause of Small Bowel Obstruction
Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytic cells. These tumors usually occur simultaneously with or follow after the onset of acute myeloid leukemia (AML) or other myeloproliferative disorders. Rarely, it is the first manifestation of AML which appears several months before the onset of leukemia. We report a case of a 48-year-old man presenting with symptoms of small bowel obstruction. Laparotomy and open biopsy were performed. Immunohistochemical studies showed that the neoplastic cells were of myeloid lineage positive for myeloperoxidase and leukocyte common antigen, but negative for CD3, 20, 56, 79a, and cytokeratin. Initially, there was no evidence of blood or bone marrow involvement suggesting acute leukemia or other myeloproliferative disorders. The findings were consistent with the diagnostic findings of solitary granulocytic sarcoma (preleukemic). However, one month later, bone marrow biopsy revealed 57% myeloblasts. Sequentially, the patient developed FAB M2 acute myeloid leukemia. Induction chemotherapy including cytarabine and idarubicine was done which led to complete remission. Allograft bone marrow transplantation was performed later, and there is no evidence of recurrence till present.
- Open Access
- 1 January 2007
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 23 (5) , 327-332
Distant Metastasis Identified Immediately after Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
- 1 January 2007
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 23 (5) , 327-332
Open AccessDistant Metastasis Identified Immediately after Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
- Open Access
- 1 January 2007
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 23 (6) , 490-496
The Characteristics of Colorectal Cancer in Patients Older than 80 Years
- 1 January 2007
- Published by Korean Society of Coloproctology in Journal of the Korean Society of Coloproctology
- Vol. 23 (6) , 490-496
Open AccessThe Characteristics of Colorectal Cancer in Patients Older than 80 Years
- 1 August 2006
- Vol. 48 (2) , 97-103
[Clinicopathologic characteristics of colorectal neuroendocrine tumor].
Colorectal neuroendocrine carcinoma is a rare neoplasm exhibiting fulminant progression and having poor prognosis. The purpose of this study is to verify the clinicopathologic characteristics of colorectal neuroendocrine carcinoma. From June 1997 to December 2004 at Asan Medical Center, ten patients were originally identified as colorectal neuroendocrine carcinoma on the basis of H&E and immunohistochemical staining (IHC). Carcinoid tumors were excluded in this study. Medical records of thirteen patients were reviewed retrospectively. Ten patients (0.2%) with colorectal neuroendocrine tumors were identified from 4,512 patients with colorectal cancer; ten neuroendocrine carcinomas and three adenocarcinomas with neuroendocrine differentiation. Their median age was 60 (41-83) years. The subjects consisted of six males and seven females. Nine tumors were located in the rectum, two in the sigmoid, and each one in the transverse colon and cecum, respectively. Nine of ten neuroendocrine carcinomas expressed synaptophysin, but chromogranin A were expressed in four. All patients were advanced at the time of diagnosis, with AJCC TNM staging: stage IIIB (n=2), stage IIIC (n=3), and stage IV (n=8). The median survival for ten neuroendocrine carcinomas and three adenocarcinomas with neuroendocrine differentiation were 16.4 months and 30 months, respectively. Five patients who received chemotherapy showed median survival of 32 months (stage III) and 17.5 months (stage IV), whereas other five patients without chemotherapy died with a median survival of 6.2 months. Colorectal neuroendocrine tumors are extremely rare showing aggressive behavior biologically, i.e fulminant early distant metastasis. Nevertheless, improved survival may be achieved by aggressive multimodality therapy.
- 1 August 2006
- Vol. 48 (2) , 97-103
[Clinicopathologic characteristics of colorectal neuroendocrine tumor].
Colorectal neuroendocrine carcinoma is a rare neoplasm exhibiting fulminant progression and having poor prognosis. The purpose of this study is to verify the clinicopathologic characteristics of colorectal neuroendocrine carcinoma. From June 1997 to December 2004 at Asan Medical Center, ten patients were originally identified as colorectal neuroendocrine carcinoma on the basis of H&E and immunohistochemical staining (IHC). Carcinoid tumors were excluded in this study. Medical records of thirteen patients were reviewed retrospectively. Ten patients (0.2%) with colorectal neuroendocrine tumors were identified from 4,512 patients with colorectal cancer; ten neuroendocrine carcinomas and three adenocarcinomas with neuroendocrine differentiation. Their median age was 60 (41-83) years. The subjects consisted of six males and seven females. Nine tumors were located in the rectum, two in the sigmoid, and each one in the transverse colon and cecum, respectively. Nine of ten neuroendocrine carcinomas expressed synaptophysin, but chromogranin A were expressed in four. All patients were advanced at the time of diagnosis, with AJCC TNM staging: stage IIIB (n=2), stage IIIC (n=3), and stage IV (n=8). The median survival for ten neuroendocrine carcinomas and three adenocarcinomas with neuroendocrine differentiation were 16.4 months and 30 months, respectively. Five patients who received chemotherapy showed median survival of 32 months (stage III) and 17.5 months (stage IV), whereas other five patients without chemotherapy died with a median survival of 6.2 months. Colorectal neuroendocrine tumors are extremely rare showing aggressive behavior biologically, i.e fulminant early distant metastasis. Nevertheless, improved survival may be achieved by aggressive multimodality therapy.
- Open Access
- 1 January 2006
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 47 (5) , 755-758
A Giant Colonic Hamartoma and Multiple Colonic Hamartomatous Polyps in a Middle-Aged Man
Park IJ, et al. Yonsei Med J. 2006 Oct;47(5):755-758. http://dx.doi.org/10.3349/ymj.2006.47.5.755
- 1 January 2006
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 47 (5) , 755-758
Open AccessA Giant Colonic Hamartoma and Multiple Colonic Hamartomatous Polyps in a Middle-Aged Man
Park IJ, et al. Yonsei Med J. 2006 Oct;47(5):755-758. http://dx.doi.org/10.3349/ymj.2006.47.5.755